Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab
Related Posts
Brownell NK, Inkelas M, Chen L, Leng M, Doan AAQ, Shannon E, Jackson N, Hsue P, Ong M, Yano E, Fonarow GC, Ziaeian B. Healthcare[...]
Vecin NM, Resnik SR, Resnik BI. Characterization and Successful Surgical Management of Suprapubic Lymphedematous Plaques in Hidradenitis Suppurativa. Dermatol Surg. 2026 Sep 1. doi: 10.1097/DSS.0000000000005329.[...]
Greb AC, Kim S, Roney A, Ting PS, Limketkai BN, Chen PH. Correction: Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver[...]